Safety of semaglutide on depressive symptoms among people with HIV in routine clinical care

More on GLP-1 and incretin signalling

• Nature Medicine·4 Oct 2026

  Semaglutide may protect kidneys by reducing vascular resistance

  

• Research Square·6 Oct 2026

  Depression was most connected in older adults in China

  

• Drug Design, Development and Therapy·5 Oct 2026

  GLP-1 agonists linked to lower dementia risk after COVID-19

  

• Journal of Global Health·4 Oct 2026

  Depression burden links to cardiometabolic multimorbidity